SLDB

SEC source: 0001209191-20-063218 · doc4.xml · nonDerivative · entry 1

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,270

SEC source: 0001209191-20-063214 · doc4.xml · nonDerivative · entry 1

Arnold Matthew Bennett · CIK 0001727991 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,933,429

SEC source: 0000899243-20-033957 · doc4.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 10,803,857

F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

SEC source: 0001209191-20-046769 · doc4.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · Wife

Disclosed balance after: 3,483

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.

SEC source: 0001209191-20-046769 · doc4.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · Wife

Disclosed balance after: 0

Underlying: Common Stock · 800 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On August 12, 2019, the reporting person's wife was granted 1,600 restricted stock units. The restricted stock units vested in two equal installments on February 12, 2020 and August 12, 2020.

F5 · derivative.expiration_date: On August 12, 2019, the reporting person's wife was granted 1,600 restricted stock units. The restricted stock units vested in two equal installments on February 12, 2020 and August 12, 2020.

SEC source: 0001209191-20-046769 · doc4.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · Wife

Disclosed balance after: 3,737

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-20-043949 · doc4.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,148,007

F3 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.

F4 · ownership.direct: Represents 1,087,376 shares held by Mr. Ganot as an individual, and 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

SEC source: 0001209191-20-043961 · doc4.xml · nonDerivative · entry 2

Morris Carl Ashley · CIK 0001727571 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,959

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.

SEC source: 0001209191-20-043952 · doc4.xml · nonDerivative · entry 2

HERSCHA LYNETTE · CIK 0001708198 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,859

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.

SEC source: 0001209191-20-043957 · doc4.xml · nonDerivative · entry 2

Ziolkowski Jennifer Lynn · CIK 0001727410 · CFO, Treasurer & Asst. Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 327,609

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.

SEC source: 0001209191-20-043981 · doc4.xml · nonDerivative · entry 2

Schneider Joel Solomon Zev · CIK 0001727649 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,115

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.

SEC source: 0001209191-20-043949 · doc4.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 35,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock units convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: On January 27, 2020, the reporting person was granted 71,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date.

F6 · derivative.expiration_date: On January 27, 2020, the reporting person was granted 71,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date.

SEC source: 0001209191-20-043949 · doc4.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,159,131

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock units convert into common stock on a one-for-one basis.

F2 · ownership.direct: Represents 1,098,500 shares held by Mr. Ganot as an individual, and 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

SEC source: 0001209191-20-043961 · doc4.xml · derivative · entry 3

Morris Carl Ashley · CIK 0001727571 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,500

Underlying: Common Stock · 11,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date

F3 · derivative.expiration_date: On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date

SEC source: 0001209191-20-043961 · doc4.xml · nonDerivative · entry 1

Morris Carl Ashley · CIK 0001727571 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-20-043952 · doc4.xml · derivative · entry 3

HERSCHA LYNETTE · CIK 0001708198 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On January 27, 2020, the reporting person was granted 32,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date.

F3 · derivative.expiration_date: On January 27, 2020, the reporting person was granted 32,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date.

SEC source: 0001209191-20-043952 · doc4.xml · nonDerivative · entry 1

HERSCHA LYNETTE · CIK 0001708198 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-20-043957 · doc4.xml · derivative · entry 3

Ziolkowski Jennifer Lynn · CIK 0001727410 · CFO, Treasurer & Asst. Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,500

Underlying: Common Stock · 11,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date.

F3 · derivative.expiration_date: On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date.

SEC source: 0001209191-20-043957 · doc4.xml · nonDerivative · entry 1

Ziolkowski Jennifer Lynn · CIK 0001727410 · CFO, Treasurer & Asst. Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-20-043981 · doc4.xml · derivative · entry 3

Schneider Joel Solomon Zev · CIK 0001727649 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,500

Underlying: Common Stock · 11,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date

F3 · derivative.expiration_date: On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date

SEC source: 0001209191-20-043981 · doc4.xml · nonDerivative · entry 1

Schneider Joel Solomon Zev · CIK 0001727649 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,156

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-20-050272 · doc4a.xml · derivative · entry 1

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · Wife

Disclosed balance after: 1,350

Underlying: Common Stock · 1,350 shares

Expires 2030-07-26

F1 · security: This amendment to the Form 4 filed on July 29, 2020 (the "Original Form 4") is being filed to add a transaction inadvertently omitted from the Original Form 4. The Original Form 4 omitted an option grant to the reporting person's wife.

F2 · derivative.exercise_date: This option was granted on July 27, 2020 and vests in four equal annual installments on the anniversary of the grant date.

SEC source: 0000899243-20-017156 · doc4.xml · derivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: This option was granted on June 16, 2020 and vests in full on the earlier to occur of June 16, 2021 and immediately prior to the Issuer's first annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

F2 · ownership.nature: Consists of options to purchase shares of the Issuer's common stock awarded to Adam Stone in connection with his role as a member of the Issuer's Board of Directors. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset. Joseph Edelman is the managing member of the Advisor.

F3 · ownership.nature: (continued from footnote 2) Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

SEC source: 0000899243-20-017154 · doc4.xml · derivative · entry 1

Stone Adam Leo · CIK 0001727440 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: This option was granted on June 16, 2020 and vests in full on the earlier to occur of June 16, 2021 and immediately prior to the Issuer's first annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0001209191-20-037691 · doc4.xml · nonDerivative · entry 1

Morris Carl Ashley · CIK 0001727571 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,050

F1 · shares: The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest in two equal installments with the first fifty percent vesting on March 11, 2021 and the second fifty percent on March 11, 2022.

SEC source: 0001209191-20-037564 · doc4.xml · derivative · entry 1

Huffines Robert Luther · CIK 0001728221 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0001209191-20-037688 · doc4.xml · nonDerivative · entry 1

HERSCHA LYNETTE · CIK 0001708198 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

F1 · shares: The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest in two equal installments with the first fifty percent vesting on March 11, 2021 and the second fifty percent on March 11, 2022.

SEC source: 0001209191-20-037698 · doc4.xml · nonDerivative · entry 1

Ziolkowski Jennifer Lynn · CIK 0001727410 · CFO, Treasurer & Asst. Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 319,700

F1 · shares: The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest in two equal installments with the first fifty percent vesting on March 11, 2021 and the second fifty percent on March 11, 2022.

SEC source: 0001209191-20-037696 · doc4.xml · nonDerivative · entry 1

Schneider Joel Solomon Zev · CIK 0001727649 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,656

F1 · shares: The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest in two equal installments with the first fifty percent vesting on March 11, 2021 and the second fifty percent on March 11, 2022.

SEC source: 0000899243-20-017092 · doc4.xml · derivative · entry 2

Koppel Adam · CIK 0001578965 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2030-06-16

F2 · derivative.exercise_date: This option was granted on June 16, 2020 to members of the Clinical Committee of the Board of Directors and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

F2 · derivative.underlying_shares: This option was granted on June 16, 2020 to members of the Clinical Committee of the Board of Directors and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0000899243-20-017092 · doc4.xml · derivative · entry 1

Koppel Adam · CIK 0001578965 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0001209191-20-037594 · doc4.xml · derivative · entry 1

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: This option was granted on June 16, 2020 and will vest in equal quarterly installments beginning three months from the date of grant and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0001209191-20-037591 · doc4.xml · derivative · entry 1

Sullivan Lynne Marie · CIK 0001727640 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0001209191-20-037585 · doc4.xml · derivative · entry 1

Shah Rajeev M. · CIK 0001619841 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

F2 · ownership.direct: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Manager"), the Reporting Person holds the option for the benefit of RA Capital Healthcare Fund, L.P. (the "Fund") and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Manager any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and Account to the Manager. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.

SEC source: 0001209191-20-037576 · doc4.xml · derivative · entry 2

Nagendran Sukumar · CIK 0001665124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2030-06-16

F2 · derivative.exercise_date: This option was granted on June 16, 2020 to members of the Clinical Committee of the Board of Directors and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

F2 · derivative.underlying_shares: This option was granted on June 16, 2020 to members of the Clinical Committee of the Board of Directors and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0001209191-20-037576 · doc4.xml · derivative · entry 1

Nagendran Sukumar · CIK 0001665124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0001209191-20-037560 · doc4.xml · derivative · entry 2

Freed Martin I · CIK 0001676653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2030-06-16

F2 · derivative.exercise_date: This option was granted on June 16, 2020 to members of the Clinical Committee of the Board of Directors and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0001209191-20-037560 · doc4.xml · derivative · entry 1

Freed Martin I · CIK 0001676653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0001209191-20-037558 · doc4.xml · derivative · entry 1

Arnold Matthew Bennett · CIK 0001727991 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

SEC source: 0001209191-20-024599 · doc4.xml · derivative · entry 1

SMITH IAN F · CIK 0001197032 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-04-15

F1 · derivative.exercise_date: This option was granted on April 15, 2020 and vests as to one-third of the total number of shares on each of the next three anniversaries of the grant date.

SEC source: 0001209191-20-018909 · doc4.xml · nonDerivative · entry 1

Morris Carl Ashley · CIK 0001727571 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,050

F1 · shares: The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest evenly over 2 years with the first fifty percent vesting on the first anniversary of the grant date and the second fifty percent vesting on the second anniversary of the grant date.

SEC source: 0001209191-20-018883 · doc4.xml · nonDerivative · entry 1

HERSCHA LYNETTE · CIK 0001708198 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

F1 · shares: The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest evenly over 2 years with the first fifty percent vesting on the first anniversary of the grant date and the second fifty percent vesting on the second anniversary of the grant date.

SEC source: 0001209191-20-018918 · doc4.xml · nonDerivative · entry 1

Schneider Joel Solomon Zev · CIK 0001727649 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,656

F1 · shares: The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest evenly over 2 years with the first fifty percent vesting on the first anniversary of the grant date and the second fifty percent vesting on the second anniversary of the grant date.

SEC source: 0001209191-20-018892 · doc4.xml · nonDerivative · entry 1

Ziolkowski Jennifer Lynn · CIK 0001727410 · CFO, Treasurer & Asst. Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 244,700

F1 · shares: The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest evenly over 2 years with the first fifty percent vesting on the first anniversary of the grant date and the second fifty percent vesting on the second anniversary of the grant date.

SEC source: 0001209191-20-009823 · doc4.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · Wife

Disclosed balance after: 2,937

SEC source: 0001209191-20-009823 · doc4.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · Wife

Disclosed balance after: 2,430

Underlying: Common Stock · 800 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On August 12, 2019, the reporting person's wife was granted 1,600 restricted stock units. The restricted stock units vest in two equal installments on February 12, 2020 and August 12, 2020.

F4 · derivative.expiration_date: On August 12, 2019, the reporting person's wife was granted 1,600 restricted stock units. The restricted stock units vest in two equal installments on February 12, 2020 and August 12, 2020.

SEC source: 0001209191-20-009823 · doc4.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · Wife

Disclosed balance after: 3,230

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-20-008912 · doc4.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · Wife

Disclosed balance after: 2,430

F1 · shares: The reported transaction involved the reporting person's wife's receipt of a grant of restricted stock units representing 2,430 shares of common stock.

SEC source: 0001209191-20-005408 · doc4.xml · derivative · entry 2

HERSCHA LYNETTE · CIK 0001708198 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,000

Underlying: Common Stock · 32,000 shares

Expires 2030-01-27

F2 · derivative.exercise_date: The restricted stock units will vest in 2 installments. Fifty percent will vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date and will vest automatically as to 100% of the unvested portion of such restricted stock unit grant upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances.

SEC source: 0001209191-20-005408 · doc4.xml · derivative · entry 1

HERSCHA LYNETTE · CIK 0001708198 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2030-01-27

F1 · derivative.exercise_date: This option was granted on January 27, 2020 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances.